Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. حسب Cristina Dolciotti (16317330)

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

Cephalometric measurement points. حسب Lijuan Liu (136685)

Time course of Path Length, LFS and Velocity during postural training. حسب Cristina Dolciotti (16317330)

Time course of 95% Area, X and Y Amplitude Sway during postural training. حسب Cristina Dolciotti (16317330)

Between-group differences in 95% Area, Y Sway Amplitude and LFS during postural training. حسب Cristina Dolciotti (16317330)

Relation between training-related changes in unipedal and bipedal stance. حسب Cristina Dolciotti (16317330)

Relation of the changes in Y Sway Amplitude and LFS induced by postural training with those in 95% Area. حسب Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: Path Length, X Sway Amplitude and Velocity. حسب Cristina Dolciotti (16317330)

Training-induced changes in bipedal stance. حسب Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: 95% Area, Y Sway Amplitude and LFS. حسب Cristina Dolciotti (16317330)

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. حسب Long Li (6555)

Selection of soil particle sampling points. حسب Xueting Ma (390540)

Change in rectal temperature following pre-medication, induction and inhalant anesthesia. حسب Jacob P. Rastas (20642173)

"…Overall, when all time points and warming treatments were combined, ACE had significantly larger decreases in body temperature versus DEX, mainly attributable to significant differences at >T30 minutes (both P < 0.05). …"

Effect of imidacloprid (Im) and rutin (Ru) administration on thoracic electrical impedance in Africanized honey bee foragers. حسب Juan P. Hernández (22216133)

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. حسب Zi-Rong Chen (9227618)

الموضوعات:

Flow diagram of the patient selection into the final analysis. حسب Zi-Rong Chen (9227618)

الموضوعات:

Patients’ demographics and clinical parameters. حسب Zi-Rong Chen (9227618)

الموضوعات:

Associations between demographic variables, In4_SED and SE changes at 6 and 12 months after 4_SED (<i><i>n</i></i> = 80). حسب Zi-Rong Chen (9227618)

الموضوعات:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study حسب Zi-Rong Chen (9227618)

الموضوعات: